基于碳青霉烯灭活法的表型试验检测GES型碳青霉烯酶的评估
该研究评估了CIM、mCIM和CIM-Tris在110株肠杆菌目、108株铜绿假单胞菌和10株鲍曼不动杆菌的GES阳性临床分离株中的性能。结果显示,检测灵敏度因菌种和GES变异型而异,mCIM在肠杆菌目中灵敏度优于CIM,CIM-Tris在铜绿假单胞菌和鲍曼不动杆菌中灵敏度高但特异性降低,提示常规实验室可能需要分子检测补充。
要点
- 肠杆菌目中mCIM灵敏度(63.6%)优于CIM(40.0%),但低美罗培南MIC导致多数漏检。
- 铜绿假单胞菌中CIM、mCIM和CIM-Tris灵敏度分别为89.1%、94.6%和100%,但CIM-Tris在非碳青霉烯酶生产者中假阳性率达50%。
- 鲍曼不动杆菌中CIM-Tris灵敏度(100%)优于CIM(25.0%)。
核心结论
- 基于CIM的方法可检测GES型碳青霉烯酶,但性能因菌种和GES变异型而异,且产GES型ESBL的菌株可能出现特异性降低。
- 常规临床实验室可能需要补充分子检测以确保准确检测GES型碳青霉烯酶。
研究设计与样本
- 评估CIM、mCIM和CIM-Tris在GES阳性临床分离株中的性能,包括110株肠杆菌目和108株铜绿假单胞菌(2010-2024年西班牙医院)及10株鲍曼不动杆菌(主要来自埃及一家医院)。
- 采用全基因组测序进行菌种确认和耐药组分析,美罗培南MIC通过肉汤微量稀释法测定。
主要发现
- 总体92.1%的分离株为GES碳青霉烯酶生产者,7.9%表达GES型ESBL。
- 肠杆菌目(主要携带blaGES-6)中,mCIM灵敏度63.6%,CIM为40.0%,MIC50为0.5 µg/mL。
- 产碳青霉烯酶的铜绿假单胞菌(主要blaGES-5)中,CIM、mCIM和CIM-Tris灵敏度分别为89.1%、94.6%和100%,CIM-Tris在50%非碳青霉烯酶生产者(主要为blaGES-1)中假阳性,MIC50 >32 µg/mL。
- 鲍曼不动杆菌中CIM-Tris灵敏度100%,CIM为25.0%。
关键数值与推荐
- 肠杆菌目:mCIM灵敏度63.6% vs CIM 40.0%,MIC50为0.5 µg/mL。
- 铜绿假单胞菌:CIM灵敏度89.1%,mCIM 94.6%,CIM-Tris 100%;CIM-Tris假阳性率50%;MIC50 >32 µg/mL。
- 鲍曼不动杆菌:CIM-Tris灵敏度100% vs CIM 25.0%。
临床怎么用
- 在肠杆菌目中,mCIM可作为GES碳青霉烯酶的表型筛查方法,但低MIC菌株易漏检。
- 在铜绿假单胞菌和鲍曼不动杆菌中,CIM-Tris灵敏度高但需注意产GES型ESBL菌株的假阳性。
- 对于GES型碳青霉烯酶的准确检测,建议结合分子检测方法。
局限性
- 鲍曼不动杆菌分离株数量较少(10株),主要来自埃及一家医院。
- 未评估其他GES变异型或未包含所有碳青霉烯酶类型的全面比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Detection of GES-type carbapenemases remains challenging because of their low prevalence and frequently weak hydrolytic activity against carbapenems. Carbapenem inactivation method (CIM)-based assays are widely used as phenotypic screening tools for carbapenemase detection; however, their performance in large collections of GES producers has not been systematically evaluated. We assessed the performance of CIM, modified CIM (mCIM), and CIM-Tris in a diverse collection of GES-producing clinical isolates, including 110 Enterobacterales and 108 Pseudomonas aeruginosa, recovered from Spanish hospitals (2010-2024), and 10 Acinetobacter baumannii isolates, mostly obtained from a hospital in Egypt. Whole-genome sequencing was carried out for species confirmation and resistome analysis. Meropenem MICs were determined by broth microdilution. Overall, 92.1% of isolates were GES-carbapenemase producers (CP), whereas 7.9% expressed GES-type extended-spectrum β-lactamases (ESBLs). In Enterobacterales (predominantly carrying blaGES-6), mCIM improved sensitivity compared with CIM (63.6% vs 40.0%), although many isolates remained undetected due to low meropenem MICs (MIC50, 0.5 µg/mL). In CP-P. aeruginosa (mainly blaGES-5), CIM, mCIM, and CIM-Tris showed sensitivities of 89.1%, 94.6%, and 100%, respectively; however, CIM-Tris yielded false-positive results in 50% of non-CP isolates (mostly blaGES-1 producers). Meropenem MICs in P. aeruginosa were higher (MIC50, >32 µg/mL). In A. baumannii, CIM-Tris improved sensitivity compared with CIM (100% vs 25.0%). These findings indicate that CIM-based methods can detect GES-type carbapenemases, but performance varies according to bacterial species and GES variant, and reduced specificity may occur in isolates producing GES-type ESBLs. Complementary molecular testing may therefore be necessary to ensure accurate detection of GES-type carbapenemases in routine clinical laboratories. IMPORTANCE: GES-type carbapenemases represent an important but underrecognized diagnostic challenge due to their low global prevalence, heterogeneous hydrolytic activity, and the limited performance data available for routine phenotypic detection methods. Although CIM-based assays are widely implemented in clinical microbiology laboratories for carbapenemase screening, their performance against GES-producing organisms has not been comprehensively evaluated across different bacterial genera and GES variants. In this study, we evaluated the performance of CIM, modified CIM (mCIM), and CIM-Tris in a large multicenter collection of well-characterized GES-producing clinical isolates, including Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii. Our findings demonstrate substantial variability in assay performance according to bacterial species and GES variant. Notably, mCIM improved sensitivity among Enterobacterales with low meropenem MICs, whereas CIM-Tris achieved excellent sensitivity in P. aeruginosa and A. baumannii but at the expense of reduced specificity in isolates producing GES-type ESBLs. To the best of our knowledge, this is the first study directly comparing multiple CIM-based approaches in such a large and taxonomically diverse collection of GES-producing isolates.
引用
- García-García S, Rodríguez-Grande J, Siller-Ruíz M, et al. Evaluation of carbapenem inactivation method-based phenotypic assays for the detection of GES-type carbapenemases in Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii. J Clin Microbiol. 2026. PMID: 42626957. doi:10.1128/jcm.00737-26
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。